Oncolytics Biotech Inc Asset Resilience Ratio

Latest as of March 2025: 83.86%

Oncolytics Biotech Inc asset resilience ratio. Oncolytics Biotech Inc (ONC) has an Asset Resilience Ratio of 83.86% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can Oncolytics Biotech Inc fund operations to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CA$16.52 Million

≈ $11.95 Million USD Cash + Short-term Investments

Total Assets

CA$19.70 Million

≈ $14.25 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Oncolytics Biotech Inc (2003–2024)

Asset resilience ratio of Oncolytics Biotech Inc from 2003 to 2024. This chart shows how Oncolytics Biotech Inc's Asset Resilience Ratio has changed over time. Read Oncolytics Biotech Inc total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Oncolytics Biotech Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Oncolytics Biotech Inc.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$2.71 Million	13.75%
Short-term Investments	CA$13.81 Million	70.11%
Total Liquid Assets	CA$16.52 Million	83.86%

Asset Resilience Insights

Very High Liquidity: Oncolytics Biotech Inc maintains exceptional liquid asset reserves at 83.86% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Oncolytics Biotech Inc Industry Peers by Asset Resilience Ratio

Compare Oncolytics Biotech Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyloris Developmentsen Sa BR:HYL	Biotechnology	1.36%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Gempharmatech Co. Ltd. A SHG:688046	Biotechnology	23.95%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%
Guangdong VTR Bio-Tech Co Ltd SHE:300381	Biotechnology	4.98%

Oncolytics Biotech Inc Asset Resilience Ratio by Year (2003–2024)

Oncolytics Biotech Inc asset resilience ratio by year from 2003 to 2024. The table below shows the annual Asset Resilience Ratio data for Oncolytics Biotech Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	83.83%	CA$16.92 Million ≈ $12.24 Million	CA$20.19 Million ≈ $14.60 Million	+66.42pp
2023-12-31	17.40%	CA$6.76 Million ≈ $4.89 Million	CA$38.82 Million ≈ $28.08 Million	-68.68pp
2022-12-31	86.08%	CA$32.14 Million ≈ $23.25 Million	CA$37.33 Million ≈ $27.01 Million	+80.15pp
2021-12-31	5.93%	CA$2.72 Million ≈ $1.97 Million	CA$45.88 Million ≈ $33.19 Million	-84.97pp
2020-12-31	90.90%	CA$31.22 Million ≈ $22.58 Million	CA$34.35 Million ≈ $24.85 Million	+18.93pp
2019-12-31	71.97%	CA$14.15 Million ≈ $10.23 Million	CA$19.66 Million ≈ $14.22 Million	-20.19pp
2018-12-31	92.16%	CA$13.70 Million ≈ $9.91 Million	CA$14.87 Million ≈ $10.75 Million	+26.95pp
2017-12-31	65.21%	CA$11.84 Million ≈ $8.56 Million	CA$18.15 Million ≈ $13.13 Million	+41.88pp
2016-12-31	23.33%	CA$3.44 Million ≈ $2.49 Million	CA$14.76 Million ≈ $10.68 Million	+15.80pp
2015-12-31	7.53%	CA$2.06 Million ≈ $1.49 Million	CA$27.38 Million ≈ $19.81 Million	-4.29pp
2014-12-31	11.82%	CA$2.03 Million ≈ $1.47 Million	CA$17.19 Million ≈ $12.44 Million	+4.72pp
2013-12-31	7.09%	CA$2.00 Million ≈ $1.45 Million	CA$28.22 Million ≈ $20.42 Million	-1.83pp
2012-12-31	8.92%	CA$1.97 Million ≈ $1.42 Million	CA$22.08 Million ≈ $15.97 Million	+3.54pp
2011-12-31	5.38%	CA$1.94 Million ≈ $1.40 Million	CA$36.02 Million ≈ $26.06 Million	-2.75pp
2010-12-31	8.12%	CA$3.61 Million ≈ $2.61 Million	CA$44.43 Million ≈ $32.14 Million	+3.40pp
2009-12-31	4.72%	CA$1.76 Million ≈ $1.27 Million	CA$37.27 Million ≈ $26.96 Million	-37.08pp
2008-12-31	41.80%	CA$5.85 Million ≈ $4.23 Million	CA$13.99 Million ≈ $10.12 Million	-18.30pp
2007-12-31	60.10%	CA$18.50 Million ≈ $13.38 Million	CA$30.78 Million ≈ $22.27 Million	-11.77pp
2006-12-31	71.87%	CA$24.12 Million ≈ $17.45 Million	CA$33.57 Million ≈ $24.28 Million	-7.83pp
2005-12-31	79.70%	CA$36.89 Million ≈ $26.69 Million	CA$46.29 Million ≈ $33.49 Million	+25.22pp
2004-12-31	54.47%	CA$21.51 Million ≈ $15.56 Million	CA$39.49 Million ≈ $28.57 Million	-15.05pp
2003-12-31	69.52%	CA$18.11 Million ≈ $13.10 Million	CA$26.05 Million ≈ $18.84 Million	--

pp = percentage points

About Oncolytics Biotech Inc

TO:ONC Canada Biotechnology

Market Cap

$1.08 Billion

CA$1.50 Billion CAD

Market Cap Rank

#17646 Global

#559 in Canada

Share Price

CA$14.90

Change (1 day)

+0.00%

52-Week Range

CA$14.90 - CA$14.90

All Time High

CA$18.60